PGP and schizophrenia: Since placental P-gp is decreased in schizophrenia during pregnancy, it can be assumed that drugs with P-gp transport used in pregnant women with schizophrenia could reach higher concentrations in the feto-placental unit and be harmful for the fetus or placenta contributing to the appearance of drug-induced fetal complications during the pharmacotherapy.